STOCK TITAN

[Form 4] OMEGA HEALTHCARE INVESTORS INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Matthew Paul Gourmand, President of Omega Healthcare Investors, reported transactions dated 09/30/2025 showing vesting and conversion of performance-based units into operating partnership units and common-stock equivalents. Two sets of Profits Interest Units (PIUs) vested into OP Units: 11,627 PIUs (Absolute TSR tranche) and 12,042 PIUs (Relative TSR tranche). Each vested PIU converts to one OP Unit with a $0 stated conversion price, and OP Units are redeemable for cash equal to the then fair market value of one share of common stock or, at the issuer’s election, one share of common stock. Following the reported transactions the filing shows beneficial ownership totals of 87,152 and 75,110 PIUs and common-stock-equivalent OP Unit totals of 140,274 and 152,316 respectively. Vesting was based on 2022–2024 performance periods and is subject to continued employment and acceleration conditions.

Matthew Paul Gourmand, presidente di Omega Healthcare Investors, ha riportato operazioni datate 09/30/2025 che mostrano lo vesting e la conversione di unità basate sulle prestazioni in unità OP e in equivalenti azionari comuni. Due set di PIUs (Profits Interest Units) si sono vestiti in OP Units: 11,627 PIUs (tranche Absolute TSR) e 12,042 PIUs (tranche Relative TSR). Ogni PIU maturato si converte in una OP Unit con un prezzo di conversione dichiarato di 0 dollari, e le OP Units sono rimborsabili in contanti pari al valore equo di mercato di una azione ordinaria o, a scelta dell’emittente, in una azione ordinaria. A seguito delle operazioni riportate, il filing mostra totali di proprietà beneficiaria di 87,152 e 75,110 PIUs e totali di OP Unit equivalenti in azioni ordinarie di 140,274 e 152,316 rispettivamente. Il vesting è stato basato sui periodi di prestazione 2022–2024 ed è soggetto a condizioni di impiego continuato e accelerazione.

Matthew Paul Gourmand, presidente de Omega Healthcare Investors, informó transacciones con fecha 30/09/2025 que muestran el vesting y la conversión de unidades basadas en desempeño en unidades OP y equivalentes a acciones comunes. Dos conjuntos de PIUs (Profits Interest Units) se adjudicaron a OP Units: 11,627 PIUs (tramo Absolute TSR) y 12,042 PIUs (tramo Relative TSR). Cada PIU adjudicado se convierte en una OP Unit con un precio de conversión declarado de $0, y las OP Units pueden canjearse por efectivo equivalente al valor razonable de mercado de una acción ordinaria o, a elección del emisor, por una acción ordinaria. Después de las transacciones reportadas, el filing muestra totales de propiedad beneficiaria de 87,152 y 75,110 PIUs, y totales de OP Units equivalentes en acciones ordinarias de 140,274 y 152,316, respectivamente. El vesting se basó en periodos de rendimiento 2022–2024 y está sujeto a empleo continuo y condiciones de aceleración.

매튜 폴 구르망, Omega Healthcare Investors의 회장, 2025년 9월 30일자로 기재된 거래를 보고하며 성과 기반 유닛의 베스팅 및 이를 OP 유닛 및 보통주 등가물로의 전환을 보여줍니다. 두 세트의 PIU(Profits Interest Units)가 OP 유닛으로 귀속되었으며: 11,627 PIU(Absolute TSR 트랜치)와 12,042 PIU(Relative TSR 트랜치). 각 귀속 PIU는 명시된 전환가액 0달러로 하나의 OP 유닛으로 전환되며, OP 유닛은 보통주 1주와 동일한 공정시장가치에 해당하는 현금으로 상환되거나, 발행인의 선택에 따라 보통주 1주로 상환될 수 있습니다. 보고된 거래 이후, 파일은 유익소유권 합계가 각각 87,15275,110 PIU, 보통주 등가 OP 유닛 합계가 각각 140,274152,316로 표시합니다. 베스팅은 2022–2024 성과 기간을 기반으로 하며 지속적 고용 및 가속 조건에 따릅니다.

Matthew Paul Gourmand, président d'Omega Healthcare Investors, a signalé des transactions datées du 30/09/2025 montrant le vesting et la conversion d'unités basées sur la performance en unités OP et en équivalents actions ordinaires. Deux ensembles d'unités d'intérêts bénéficiaires (PIUs) se sont vestées en unités OP : 11 627 PIUs (tranche Absolute TSR) et 12 042 PIUs (tranche Relative TSR). Chaque PIU vesté se convertit en une OP Unit avec un prix de conversion déclaré de 0 $, et les OP Units sont rachetables en espèces égales à la juste valeur marchande d'une action ordinaire ou, au choix de l'émetteur, en une action ordinaire. Suite aux transactions rapportées, le dossier montre des totaux de propriété bénéficiaire de 87 152 et 75 110 PIUs, et des totaux d'OP Units équivalentes en actions ordinaires de 140 274 et 152 316, respectivement. Le vesting était basé sur les périodes de performance 2022–2024 et est soumis à l'emploi continu et à des conditions d'accélération.

Matthew Paul Gourmand, Präsident von Omega Healthcare Investors, meldete Transaktionen vom 30.09.2025, die das Vesting und die Umwandlung leistungsbasierter Einheiten in OP-Einheiten und Aktienäquivalente zeigen. Zwei Sätze von Profits Interest Units (PIUs) wurden in OP-Einheiten umgewandelt: 11.627 PIUs (Absolute TSR-Tranche) und 12.042 PIUs (Relative TSR-Tranche). Jede vestete PIU wandelt sich zu einer OP-Einheit mit einem festgelegten Umtauschpreis von 0 USD um, und OP-Einheiten sind gegen Bargeld in Höhe des aktuellen Marktwerts einer Stammaktie einlösbar oder, nach Wahl des Emittenten, gegen eine Stammaktie. Nach den berichteten Transaktionen zeigen die Einträge Beneficial Ownership Gesamtbeträge von 87.152 bzw. 75.110 PIUs und Gesamtsumme der OP-Einheiten in Aktienäquivalenten von 140.274 bzw. 152.316. Das Vesting basierte auf den Leistungszeiträumen 2022–2024 und unterliegt Bedingungen wie fortgesetzter Beschäftigung und Beschleunigung.

Matthew Paul Gourmand، رئيس Omega Healthcare Investors، أبلغ عن معاملات بتاريخ 30/09/2025 تُظهر الاستحقاق والتحويل للوحدات القائمة على الأداء إلى وحدات OP وإلى مكافئات أسهم عادية. مجموعتان من وحدات فائدة الأرباح (PIUs) استُحقت لتتحول إلى وحدات OP: 11,627 PIU (الشرائح Absolute TSR) و 12,042 PIU (الشرائح Relative TSR). كل PIU مستحق يتحول إلى وحدة OP بسعر تحويل مُعلن قدره 0 دولار، وتُستبدل وحدات OP نقداً يساوي القيمة السوقية العادلة لسهم واحد من الأسهم العادية أو، حسب اختيار المُصدر، بسهم واحد من الأسهم العادية. عقب المعاملات المبلاغ عنها، يُظهر الملف إجماليات الملكية المستفيدة من 87,152 و< b>75,110 PIU، وإجماليات وحدات OP المكافئة للأسهم العادية من 140,274 و152,316 على التوالي. كان vesting مبنيًا على فترات الأداء 2022–2024 وهو خاضع لشرط الاستمرار في العمل ووجود شروط تسريع.

Matthew Paul Gourmand,Omega Healthcare Investors 的主席,报告日期为 2025-09-30 的交易,显示基于业绩的单位归属和转为运营合伙单位(OP 单位)及普通股等价物的转换。两组利润权益单位(PIUs)归属为 OP 单位:11,627 PIU(绝对 TSR 阶段)和 12,042 PIU(相对 TSR 阶段)。每个已归属的 PIU 转换为一个 OP 单位,声明的转换价为 0 美元,OP 单位可按当时普通股的公允市场价值现金赎回,或由发行人选择以一股普通股赎回。报告的交易之后,备案显示受益所有权总计为 87,15275,110 PIU,普通股等价 OP 单位总计为 140,274152,316,分别。归属基于 2022–2024 年度绩效期,且受持续就职及加速条件约束。

Positive
  • Performance-based compensation vested, demonstrating alignment of executive pay with multi-year TSR goals
  • Conversion to OP Units that are redeemable for cash or exchangeable for common stock, clarifying value realization mechanics
Negative
  • Potential dilution from OP Units being redeemable or exchangeable for common shares, increasing outstanding common-stock equivalents

Insights

TL;DR: Insider reported routine performance-based vesting converting PIUs to OP Units and common-stock equivalents, increasing beneficial holdings without cash purchase.

The Form 4 documents scheduled vesting on 09/30/2025 of performance-based Profits Interest Units tied to the 2022–2024 performance period. The vested amounts—11,627 and 12,042 PIUs—convert to OP Units and are recorded with $0 conversion price; OP Units are redeemable for cash or exchangeable for common stock. This increases the reporting person’s beneficial ownership in both PIU and common-stock-equivalent terms, reflecting compensation realization rather than an open-market purchase or sale.

TL;DR: Transaction reflects compensation plan mechanics and standard disclosure of vested long-term incentive units; governance implications are routine.

The filing clarifies the mechanics and conditions: PIUs vest based on Absolute and Relative Total Shareholder Return metrics for 2022–2024 and are subject to continued employment and acceleration provisions. The disclosure of OP Unit redemption mechanics (cash at fair market value or issuance of one share) is important for assessing potential dilution and alignment of executive incentives with shareholders, but no new terms or departures from standard plan provisions are disclosed in this Form 4.

Matthew Paul Gourmand, presidente di Omega Healthcare Investors, ha riportato operazioni datate 09/30/2025 che mostrano lo vesting e la conversione di unità basate sulle prestazioni in unità OP e in equivalenti azionari comuni. Due set di PIUs (Profits Interest Units) si sono vestiti in OP Units: 11,627 PIUs (tranche Absolute TSR) e 12,042 PIUs (tranche Relative TSR). Ogni PIU maturato si converte in una OP Unit con un prezzo di conversione dichiarato di 0 dollari, e le OP Units sono rimborsabili in contanti pari al valore equo di mercato di una azione ordinaria o, a scelta dell’emittente, in una azione ordinaria. A seguito delle operazioni riportate, il filing mostra totali di proprietà beneficiaria di 87,152 e 75,110 PIUs e totali di OP Unit equivalenti in azioni ordinarie di 140,274 e 152,316 rispettivamente. Il vesting è stato basato sui periodi di prestazione 2022–2024 ed è soggetto a condizioni di impiego continuato e accelerazione.

Matthew Paul Gourmand, presidente de Omega Healthcare Investors, informó transacciones con fecha 30/09/2025 que muestran el vesting y la conversión de unidades basadas en desempeño en unidades OP y equivalentes a acciones comunes. Dos conjuntos de PIUs (Profits Interest Units) se adjudicaron a OP Units: 11,627 PIUs (tramo Absolute TSR) y 12,042 PIUs (tramo Relative TSR). Cada PIU adjudicado se convierte en una OP Unit con un precio de conversión declarado de $0, y las OP Units pueden canjearse por efectivo equivalente al valor razonable de mercado de una acción ordinaria o, a elección del emisor, por una acción ordinaria. Después de las transacciones reportadas, el filing muestra totales de propiedad beneficiaria de 87,152 y 75,110 PIUs, y totales de OP Units equivalentes en acciones ordinarias de 140,274 y 152,316, respectivamente. El vesting se basó en periodos de rendimiento 2022–2024 y está sujeto a empleo continuo y condiciones de aceleración.

매튜 폴 구르망, Omega Healthcare Investors의 회장, 2025년 9월 30일자로 기재된 거래를 보고하며 성과 기반 유닛의 베스팅 및 이를 OP 유닛 및 보통주 등가물로의 전환을 보여줍니다. 두 세트의 PIU(Profits Interest Units)가 OP 유닛으로 귀속되었으며: 11,627 PIU(Absolute TSR 트랜치)와 12,042 PIU(Relative TSR 트랜치). 각 귀속 PIU는 명시된 전환가액 0달러로 하나의 OP 유닛으로 전환되며, OP 유닛은 보통주 1주와 동일한 공정시장가치에 해당하는 현금으로 상환되거나, 발행인의 선택에 따라 보통주 1주로 상환될 수 있습니다. 보고된 거래 이후, 파일은 유익소유권 합계가 각각 87,15275,110 PIU, 보통주 등가 OP 유닛 합계가 각각 140,274152,316로 표시합니다. 베스팅은 2022–2024 성과 기간을 기반으로 하며 지속적 고용 및 가속 조건에 따릅니다.

Matthew Paul Gourmand, président d'Omega Healthcare Investors, a signalé des transactions datées du 30/09/2025 montrant le vesting et la conversion d'unités basées sur la performance en unités OP et en équivalents actions ordinaires. Deux ensembles d'unités d'intérêts bénéficiaires (PIUs) se sont vestées en unités OP : 11 627 PIUs (tranche Absolute TSR) et 12 042 PIUs (tranche Relative TSR). Chaque PIU vesté se convertit en une OP Unit avec un prix de conversion déclaré de 0 $, et les OP Units sont rachetables en espèces égales à la juste valeur marchande d'une action ordinaire ou, au choix de l'émetteur, en une action ordinaire. Suite aux transactions rapportées, le dossier montre des totaux de propriété bénéficiaire de 87 152 et 75 110 PIUs, et des totaux d'OP Units équivalentes en actions ordinaires de 140 274 et 152 316, respectivement. Le vesting était basé sur les périodes de performance 2022–2024 et est soumis à l'emploi continu et à des conditions d'accélération.

Matthew Paul Gourmand, Präsident von Omega Healthcare Investors, meldete Transaktionen vom 30.09.2025, die das Vesting und die Umwandlung leistungsbasierter Einheiten in OP-Einheiten und Aktienäquivalente zeigen. Zwei Sätze von Profits Interest Units (PIUs) wurden in OP-Einheiten umgewandelt: 11.627 PIUs (Absolute TSR-Tranche) und 12.042 PIUs (Relative TSR-Tranche). Jede vestete PIU wandelt sich zu einer OP-Einheit mit einem festgelegten Umtauschpreis von 0 USD um, und OP-Einheiten sind gegen Bargeld in Höhe des aktuellen Marktwerts einer Stammaktie einlösbar oder, nach Wahl des Emittenten, gegen eine Stammaktie. Nach den berichteten Transaktionen zeigen die Einträge Beneficial Ownership Gesamtbeträge von 87.152 bzw. 75.110 PIUs und Gesamtsumme der OP-Einheiten in Aktienäquivalenten von 140.274 bzw. 152.316. Das Vesting basierte auf den Leistungszeiträumen 2022–2024 und unterliegt Bedingungen wie fortgesetzter Beschäftigung und Beschleunigung.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Gourmand Matthew Paul

(Last) (First) (Middle)
303 INTERNATIONAL CIRCLE
SUITE 200

(Street)
HUNT VALLEY MD 21030

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
OMEGA HEALTHCARE INVESTORS INC [ OHI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President
3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Profits Interest Units (1)(2) 09/30/2025 M 11,627 (3) (3) OP Units 11,627 $0 87,152 D
Profits Interest Units (1)(2) 09/30/2025 M 12,042 (4) (4) OP Units 12,042 $0 75,110 D
OP Units (2) 09/30/2025 M 11,627 (2) (2) Common Stock 11,627 $0 140,274 D
OP Units (2) 09/30/2025 M 12,042 (2) (2) Common Stock 12,042 $0 152,316 D
Explanation of Responses:
1. Represents Profits Interest Units ("PIUs") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each PIU represents a contingent right to receive one unit of limited partnership interest (an "OP Unit") in the Operating Partnership upon vesting and the satisfaction of certain tax-driven economic requirements.
2. Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer common stock, subject to adjustment as set forth in the partnership agreement. The OP Units have no expiration date.
3. Represents 25% of the PIUs that vested into OP Units at the end of each calendar quarter in 2025 based on the Absolute Total Shareholder Return for the 2022-2024 performance period, subject to continued employment and accelerated vesting under certain circumstances.
4. Represents 25% of the PIUs that vested into OP Units at the end of each calendar quarter in 2025 based on the Relative Total Shareholder Return for the 2022-2024 performance period, subject to continued employment and accelerated vesting under certain circumstances.
/s/ Meghan C. Lyons, Attorney-in-Fact 10/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 for OHI filed by Matthew Paul Gourmand report?

The Form 4 reported vesting on 09/30/2025 of performance-based Profits Interest Units (11,627 and 12,042 PIUs) that converted into OP Units and common-stock equivalents.

How many PIUs vested and converted according to the filing?

The filing shows 11,627 PIUs (Absolute TSR tranche) and 12,042 PIUs (Relative TSR tranche) vested and converted on 09/30/2025.

What do OP Units represent and how can they be settled?

Each OP Unit is redeemable at the holder’s election for cash equal to the then fair market value of one share of common stock, or, at the issuer’s election, for one share of common stock.

Are these transactions purchases or compensation realizations?

These transactions reflect compensation vesting under the company’s performance plan, not open-market purchases.

What performance period determined vesting for these PIUs?

Vesting was based on the 2022–2024 performance period, measured by Absolute and Relative Total Shareholder Return.
Omega Healthcare

NYSE:OHI

OHI Rankings

OHI Latest News

OHI Latest SEC Filings

OHI Stock Data

12.45B
294.37M
0.21%
77.01%
3.72%
REIT - Healthcare Facilities
Real Estate Investment Trusts
Link
United States
HUNT VALLEY